Protocol Deviation Log (TILA278-201)
📚 Part of the TILA-278 Regulatory Dossier — Reader's Guide. This article shows the live document; edits to the source appear here automatically.
This is a mock / simulation document, made for a portfolio and for learning. The drug (GLPI-103), the sponsor, the people, and the data are all fictional. It is not a real regulatory submission and has no clinical, legal, or regulatory standing. What is real is the shape of the thing — the document structure, the standards it follows, and the analysis methods; the content inside is illustrative.
What it is. Protocol Deviation Log (TILA278-201)
Why it exists. A quality record showing how the program controls quality and builds the audit trail.
How it is produced here. It is a quality record: a plan or log that shows how the program controls quality and builds the audit trail sitting behind every other document.
Format & governing standard. —
Protocol Deviation Log (TILA278-201)
Document ID: QA-002
Version: 1.0
Change History: 1.0 — Initial issue.
Standard(s): ICH E6(R3)
Protocol Deviation Log — TILA278-201
Register of protocol deviations for TILA278-201, each classified (major/minor), with root cause, impact on subject safety and data integrity, and CAPA linkage. Reviewed for the clinical study report's deviation summary. ICH E6(R3).
Comments (0)
No comments yet. Be the first to say something!